DR. BARBARA COONS, MD

Plain English
This research studied how proteins are produced and broken down in different tissues of developing mouse embryos. The researchers injected specific amino acids into pregnant mice and found that protein turnover rates varied from 0.0000381 to 0.424 hours across different organs, indicating that some organs, like the liver and brain, have similar protein production rates but differ significantly in how quickly they turnover proteins. Understanding these dynamics is important because they help researchers know how fetus organs develop properly. Who this helps: This helps scientists and medical professionals studying fetal development and related health issues.

Plain English
This study looked at a treatment called in utero hematopoietic cell transplantation (IUHCT) for babies who have genetic blood disorders, like sickle cell disease. Researchers found that babies receiving this treatment were much less likely to develop graft-versus-host disease (GVHD) compared to newborns who had the same cells transplanted after birth. Specifically, they showed that this resistance was linked to higher levels of a substance called interleukin-10 in fetal blood, which helps regulate the immune response and prevent GVHD. Who this helps: This research benefits patients with congenital blood disorders and their families.

Plain English
This study looked at how proteins are made and broken down in mouse fetuses to understand their development better. The researchers found that, on average, about 17.5% of injected amino acids were incorporated into developing tissues, with protein turnover rates varying significantly across different organs. This information is important because it helps us understand how protein production affects the development of organs and could provide insights into preventing developmental problems. Who this helps: This helps researchers and doctors who study fetal development and related health issues.

Plain English
This study explored how contrast-enhanced ultrasound (CEUS) can measure blood flow to the brain in newborn lambs that were placed in a special support system outside the womb. The researchers found that while certain measurements of brain blood flow were not affected by the lambs' heart rate or blood pressure, they were closely linked to the amount of oxygen delivered and overall blood flow. This is important because it shows that CEUS can give doctors valuable information about brain health in newborns, which could help them detect issues earlier than with traditional methods. Who this helps: This benefits doctors monitoring the brain health of premature infants.

Plain English
This study looked at how the drug sildenafil affects fetal lambs during extracorporeal support, which is a system that provides life support outside the womb. Researchers found that administering sildenafil at a dose of 0.5 mg/kg per day effectively reached the desired drug levels in the blood and temporarily lowered blood pressure and lung resistance without causing harmful effects like acidosis. This research is important because it helps us understand how sildenafil might be safely used in prenatal treatments for fetal conditions, especially in cases like pulmonary hypertension. Who this helps: This benefits patients, particularly those expecting babies with certain fetal health issues.

Plain English
This study looked at a type of fetal surgery called fetoscopy, which uses a less invasive method to fix birth defects, focusing on how to safely introduce gas into the fetus. Researchers tested different conditions of gas exposure on fetal sheep and found that using warm, humidified carbon dioxide without exposing the umbilical cord was safe for the fetus, showing no harmful changes in blood or brain circulation. This is important because it supports the use of safer surgical techniques that can help treat common birth defects without putting the fetus at risk. Who this helps: This benefits patients with birth defects and their families by providing safer treatment options.

Plain English
This study looked at how a treatment called histrelin affects growth in children with congenital adrenal hyperplasia (CAH), a condition that can cause early puberty and shorter adult height. Researchers followed 15 children who received histrelin for an average of 3 years and found that their bone age (a measure of physical development) improved and their predicted adult height increased by an average of 7.1 centimeters. While this treatment helped growth significantly, the children still did not reach the height expected based on their parents’ heights. Who this helps: This research benefits children with CAH and their families by offering a potential treatment for growth issues.

Plain English
This study looked at how a type of immune cell, called regulatory T cells, can help transplant stem cells from a donor into a fetus late in pregnancy. Researchers found that when they added these regulatory T cells to the transplants, the cells successfully integrated and functioned well without causing harmful immune reactions. This is significant because it means that the window for performing these types of transplants could be extended beyond the typical first trimester, potentially benefiting more fetuses at risk of genetic blood disorders. Who this helps: This helps unborn babies with congenital blood disorders.

Plain English
This study looked at how adding nitric oxide (NO) to the gas that helps oxygenate blood during a specific procedure called extracorporeal membrane oxygenation (ECMO) might affect newborn lambs. The researchers found that while all lambs experienced a drop in platelet counts, those receiving NO maintained significantly higher platelet levels at 24 hours—about 62% of their starting levels compared to just 32% for those not receiving NO. Additionally, the levels of a protein indicating platelet activation were lower in the NO-treated group, suggesting that the treatment might help protect platelets during the procedure. Who this helps: This research benefits newborn patients who require ECMO therapy.

Plain English
This study looked at how a special supportive environment for premature lambs, called EXTEND, affects their intestinal development compared to lambs that grow inside their mother. The researchers found that the intestines of the EXTEND-supported lambs showed normal growth and functioning, with healthy structures and movements. However, these lambs had fewer immune cells, which is important for fighting infections. Who this helps: Patients, especially premature infants, may benefit from improvements in their care.

Plain English
Researchers developed a special support system called EXTEND for extremely premature lambs to see how well their cells used oxygen, which is important for their health. They studied four premature lambs, which were supported for about three to four weeks, and compared them to five control lambs. They found that the supported lambs had normal oxygen consumption rates in most organs, with their liver showing even better function than the control group. This means that EXTEND can effectively support the health of severely premature lambs, which is crucial for improving care for premature infants in general. Who this helps: This helps premature infants and their healthcare providers.

Plain English
This study investigated how antibodies from pregnant mice affect the success of fetal stem cell transplants. Researchers found that when the mother's immune system had antibodies against the donor's cells, all of the transplanted cells were rejected by the fetus, leading to a 100% rejection rate in those cases, compared to success in all pregnancies where the mother's antibodies were not harmful. This is important because it highlights the need to test pregnant women for these antibodies before performing stem cell transplants on their babies to improve the chances of successful treatment. Who this helps: This helps patients undergoing fetal stem cell transplants and their doctors.

Plain English
This study looked at how much fluid is given to kids who are admitted for trauma care and found that giving more than 60 ml of fluid per kilogram of body weight in the first 24 hours can cause serious problems. Specifically, patients who received this high fluid volume experienced longer stays in the ICU and overall hospital, used ventilators more often, and took longer to start eating regular food again. These findings are important because they suggest that doctors should be careful with how much fluid they give to injured children to avoid negative effects on their recovery. Who this helps: This helps pediatric trauma patients and their doctors by guiding safer treatment practices.

Plain English
This study explored a technique called in utero transplantation (IUT), where stem cells or other therapeutic substances are introduced into fetuses early in pregnancy, which could allow for treating diseases before birth without the harsh treatments often needed after birth. The researchers developed a method to deliver these cells using two approaches: intravenously and through the amniotic sac, showing that both methods can successfully improve the understanding of treating blood disorders like sickle cell disease and gene therapy. These findings are important because they highlight a potential way to effectively treat congenital conditions early and more safely before a baby is born. Who this helps: Patients with congenital blood disorders and their families.

Plain English
Researchers used CRISPR gene-editing technology to fix faulty genes in mouse fetuses before birth, targeting genes that cause high cholesterol and a fatal liver disease called hereditary tyrosinemia type 1. The edited genes persisted and functioned properly after the mice were born—cholesterol levels dropped in one group, and the other group survived a disease that normally kills them. This proof-of-concept shows that prenatal gene editing could potentially prevent or cure certain genetic diseases before a baby is even born.